23 Matching Annotations
  1. Oct 2026
    1. Case Report

      Case#: Patient (case report), male, 1 month old, ethnicity unknown

      DiseaseAssertion: Pompe disease

      FamilyInfo: No history of consanguinity in parents. The patient has a 15 months old sibling that is healthy.

      Family medical history was notable for tuberous sclerosis in the patient’s father’s first cousin.

      CasePresentingHPOs: HP:0200128, HP:0001639, HP:0002240

      (Biventricular hypertrophy, Hypertrophic cardiomyopathy, Hepatomegaly,

      CaseHPOFreeText: Echogenic mass within the left ventricle.

      Short-axis images revealed the possibility of an additional mass within the left ventricle adjacent to the papillary muscles

      Right axis deviation

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      Normal results were noted for levels of plasma amino acids, lactate and pyruvate, total and free carnitine, and acylcarnitine compounds. Urine organic acid quantitation was normal.

      PR interval was normal

      CasePreviousTesting: The serum creatine kinase was elevated (478 U/L; normal 60–305 U/L).

      GAA activity in whole blood from a blood spot was 1.8 pmol/punch/hour (control 10–49 pmol/punch/hour)

      The GAA gene was sequenced.

      Variant 1: NM_000152.5(GAA):c.525del (p.Glu176fs)

      ClinVar: 4033

      CAID: CA220406

      gnomAD: N/A

      Variant 2: NM_000152.5(GAA):c.1927G>A (p.Gly643Arg)

      ClinVar: 4023

      CAID: CA116596

      gnomAD: Highest population MAF=0.00003667 (Euroean (non-Finnish))

      ParentalGenotype:N/A

      PreviouslyPublished:N/A

    1. 7

      Case#: Patient 7, Gender N/A, Onset 3-4 months. Death around 1-2 years, Southeast Asian

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: P:0001639. HP:0005165, HP:0001270, HP:0002240

      (Dyspnea, Shortened PR interval, Motor delay, Hepatomegaly

      CaseHPOFreeText: BVH, Severe MR, SDD, CK 550u/l, EF

      CaseNotHPOs:

      CaseNotHPOFreeText:

      CasePreviousTesting: Creatine Kinase enzyme 550u/l, Ejection fraction 30%, GAA enzyme activity in leukocytes was 0.05% of normal control value.

      PCR of all exons was performed and subsequently subjected to capillary Sanger sequencing in both directions

      Variant 1: NM_000152.5(GAA):c.1411_1414del (p.Glu471fs)

      ClinVar: 188874

      CAID: CA274067

      gnomAD: Highest population MAF = 0.0002513 in East Asian

      Variant 2: NM_000152.5(GAA):c.1933G>C (p.Asp645His)

      ClinVar: 189013

      CAID: CA274256

      gnomAD: Highest population MAF = 0.00005534 (East Asian)

      ParentalGenotype: Father was the carrier of variant 1 NM_000152.5(GAA):c.1411_1414del (p.Glu471fs)

      mother was carrier of variant 2 NM_000152.5(GAA):c.1933G>C (p.Asp645His)

      PreviouslyPublished: N/A

    2. 1

      Case#: Patient 1, gender N/A, Age of onset was 7-8 months (died at 3 years of age), Southeast Asian

      DiseaseAssertion: Pompe Disease

      FamilyInfo:

      CasePresentingHPOs: HP:0001252, HP:0001270, HP:0001638, HP:0005165 (Muscular Hypotonia, Motor delay, Cardiomyopathy, Shortened PR interval)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: GAA activity in leukocytes was 0% of the normal control value.

      PCR of all exons was performed and subsequently subjected to capillary Sanger sequencing in both directions

      Variant1: NM_000152.5(GAA):c.876C>G (p.Tyr292Ter)

      ClinVar: 637958

      CAID: CA401363871

      gnomAD: N/A

      Variant2: NM_000152.5:c.1003G>A (p.Gly335Arg)

      ClinVar: 972790

      CAID: CA501005

      gnomAD: Highest population MAF = 0.00003266 (South Asian).

      ParentalGenotype: Patient inherited variant 1 (NM_000152.5(GAA):c.876C>G (p.Tyr292Ter) from father.

      Variant 2 (c.1003G>A (p.Gly335Arg)) was inherited from mother PreviouslyPublished:N/A

    3. 4

      Case#: Patient 4, Gender N/A, onset at 3-4 months. Died at 9 months, Southeast Asian

      DiseaseAssertion:Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002094 HP:0001639. HP:0005165, HP:0001270 (Hypertrophic Cardiomyopathy, Dyspnea, Shortened PR interval, Motor delay )

      CaseHPOFreeText: BVH, Died from dehydration (diarrhea)

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: GAA activity in leukocytes was 0% of normal control value.

      PCR of all exons was performed and subsequently subjected to capillary Sanger sequencing in both directions

      Variant 1: c.1225dup (p.Asp409GlyfsX95)

      ClinVar: N/A

      CAID: CA923726362

      gnomAD: N/A

      Variant 2: c.2024_2026delACA (p.Asn675del)

      ClinVar: 189006

      CAID: CA274244

      gnomAD: Highest population MAF = 0.0001106 (East asians)

      ParentalGenotype: Father was carrier for Variant1 c.1226insG (p.Asp409GlyfsX95)

      Mother was carrier of Variant 2 c.2024_2026delACA (p.Asn675del)

      PreviouslyPublished: N/A

    4. 5

      Case#: Patient 5, Gender N/A, Onset at 5-6 months. Death at 1.5 years of age, Southeast Asian

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002094 HP:0001639. HP:0005165, HP:0001270, HP:0001252, HP:0001714, HP:0002090

      (Hypertrophic Cardiomyopathy, Dyspnea, Shortened PR interval, Motor delay, Muscular hypotonia, Ventricular hypertrophy, Pneumonia )

      CaseHPOFreeText: Death from heart failure and pneumonia

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: GAA activity in leukocytes was 0% of normal control value.

      PCR of all exons was performed and subsequently subjected to capillary Sanger sequencing in both directions

      Variant 1: NM_000152.5(GAA):c.1538A>G (p.Asp513Gly)

      ClinVar: 638014

      CAID: CA401367134

      gnomAD: N/A

      ParentalGenotype: Both parents carried the .1538A>G (p.Asp513Gly) variant in the GAA gene. There was no parental consanguinity

      PreviouslyPublished: N/A

    5. 8

      Case#: Patient 8, Gender N/A, Onset at 1-2 months. Death at 13 months. Southeast Asian

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002240, HP:0001252, HP:0002789, HP:0001698 (Hepatomegaly, Muscular hypotonia, Tachypnea, Pericardial effusion)

      CaseHPOFreeText: Hepatomegaly is mild, Pericardial effusion is mild, BHV, SDD

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: Normal PR Interval

      CasePreviousTesting: GAA activity in leukocytes was 1.46% of normal control value.

      PCR of all exons was performed and subsequently subjected to capillary Sanger sequencing in both directions

      Variant: NM_000152.5(GAA):c.877G>A (p.Gly293Arg)

      ClinVar: 4036

      CAID: CA116622

      gnomAD: Highest population MAF = 0.00005704 (Latino)

      ParentalGenotype: Both parents were carriers of the variant c.877G>A (p.Gly293Arg)

      PreviouslyPublished: N/A

    6. 6

      Case#: Patient 6, Gender N/A, Onset at 5-6 months. Death around 2 years old, Southeast Asian

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: P:0001639. HP:0005165, HP:0001270, HP:0011968

      (Dyspnea, Shortened PR interval, Motor delay, Feeding difficulties,

      CaseHPOFreeText: FTT, BVH, Severe MR)

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: GAA activity in leukocytes was 0.43% of normal control value.

      PCR of all exons was performed and subsequently subjected to capillary Sanger sequencing in both directions

      Variant: NM_000152.5(GAA):c.781G>A (p.Ala261Thr)

      ClinVar: 456438

      CAID: CA8815016

      gnomAD: Highest population MAF = 0.00009799 (South Asian)

      ParentalGenotype: Father and Mother were carriers of the variant c.781G>A (p.Ala261Thr)

      PreviouslyPublished: N/A

    1. 1

      Case#: Patient 1, Gender N/A, age N/A, ethnicity unknown

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001638, HP:0003756

      (Cardiomyopathy, Skeletal myopathy)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: Sequence analysis of the GAA gene was performed in a CLIA and CAP certified laboratory.

      Cross Reactive Immune reaction was indeterminate in peripheral blood mononuclear cells (PBMCs)

      Cross Reactive Immune reaction was negative in Dried blood spots.

      Variant 1: c.437delT (p.Met146ArgfsX7)

      ClinVar: N/A

      CAID: N/A

      gnomAD: N/A

      Variant 2: NM_000152.5(GAA):c.2237G>A (p.Trp746Ter)

      ClinVar: 280063

      CAID: CA8815664

      gnomAD: Two variants with same consequence (protein) were identified.

      Highest population MAF = 0.00004011 (African)

      Highest population MAF = 0.000008834 (European non-Finnish)

      ParentalGenotype: N/A

      Previously published: N/A

    2. 3

      Case#: Patient 3, Gender unknown, age unknown, ethnicity unknown

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001638, HP:0003756

      (Cardiomyopathy, Skeletal myopathy)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: Sequence analysis of the GAA gene was performed in a CLIA and CAP certified laboratory. Cross Reactive Immune reaction was indeterminate in peripheral blood mononuclear cells (PBMCs)

      Cross Reactive Immune reaction was negative in Dried blood spots.

      Variant: NM_000152.5(GAA):c.2560C>T (p.Arg854Ter)Cite this record

      ClinVar: 4034

      CAID: CA340130

      gnomAD: Highest population MAF= 0.001891 (African)

      ParentalGenotype: N/A

      PreviouslyPublished:N/A

    3. 4

      Case#: Patient 4, Gender unknown, age unknown, ethnicity unknown

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001638, HP:0003756

      (Cardiomyopathy, Skeletal myopathy)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: Sequence analysis of the GAA gene was performed in a CLIA and CAP certified laboratory. Cross Reactive Immune reaction was indeterminate in peripheral blood mononuclear cells (PBMCs)

      Cross Reactive Immune reaction was not available in Dried blood spots.

      Variant: NM_000152.5(GAA):c.2560C>T (p.Arg854Ter)

      ClinVar: 4034

      CAID:CA340130

      gnomAD: Highest population MAF= 0.001891 (African)

      ParentalGenotype: N/A

    4. 6

      Case#: Patient 6, gender unknown, age unknown, ethnicity unknown

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001638, HP:0003756

      (Cardiomyopathy, Skeletal myopathy)

      CaseHPOFreeText:N/A

      CaseNotHPOs: N.A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: Sequence analysis of the GAA gene was performed in a CLIA and CAP certified laboratory.

      Cross Reactive Immune reaction was negative in peripheral blood mononuclear cells (PBMCs)

      Cross Reactive Immune reaction was not available in Dried blood spots.

      Variant: NM_000152.5(GAA):c.2297A>C (p.Tyr766Ser)

      ClinVar: 420102

      CAID: CA8815680

      gnomAD: Highest population MAF= 0.00005441 (East asian)

      ParentalGenotype: N/A

      PreviouslyPublished:N/A

    1. LOPD patient #1

      Case#: LOPD patient #1, Male, 69, ethnicity unknown.

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002094, HP:0006554, HP:0012378, HP:0001324 (Dyspnea, Acute respiratory failure, Fatigue, Lower Girdle Muscle Weakness and Upper Girdle Muscle Weakness)

      CaseHPOFreeText: Dyspnea was present during exercise, not at rest. Lower Girdle Muscle Weakness and Upper Girdle Muscle Weakness share the same HPO.

      CaseNotHPOs:

      CaseNotHPOFreeText: Patient has normal creatine phosphokinase levels, No Dyspnea at rest, No Ortopnea, No Airways infections, no myalgia

      CasePreviousTesting: GAA gene sequencing to asses genotype.

      GAA activity was reduced (0.36 microMol/L/h) in reference to standard (10.1 ± 6.6 microMol/L/h) This was measured by dried blood spot .

      GAA muscle activity was 3.6 pmol/min/mg, no reference range was provided

      Variant: Variant 1: NM_000152.5:c.-32-13T>G

      ClinVar: 4027

      CAID: CA116606

      gnomAD: MAF= 0.005541 (Ashkenazi Jewish)

      Variant 2: NM_000152.5(GAA):c.1564C>G (p.Pro522Ala)

      ClinVar:371277

      CAID:CA16041893

      gnomAD: N/A

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    1. Case 2

      Case#: Case 2, Boy, Death at 7 months old, Hispanic

      DiseaseAssertion: Pompe disease

      FamilyInfo: Parents were carriers of the variant in Patient 2 (Figure 2.C)

      CasePresentingHPOs: HP:0002205, HP:0001945, HP:0000980, HP:0001290, HP:0000158, HP:0002791, HP:0002240, HP:0200128

      (Recurrent respiratory infections, Fever, Pallor, Generalized hypotonia, Macroglossia, Hypoventilation, Hepatomegaly, Biventricular hypertrophy )

      CaseHPOFreeText: Systolic and diastolic dysfunction.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: Ejection fraction was 40%

      Serum Creatine Kinase levels were 650 IU/L

      GAA enzyme activity on dried blood spots was 0.6 pmol/L, below normal levels (normal range: 10.0- 49 pmol/L).

      Variant: c.1987delC

      ClinVar: N/A

      CAID: N/A

      gnomAD: N/A

      ParentalGenotype: Both parents are carriers of the variant c.1987delC

      PreviouslyPublished: N/A

    2. Case 1

      Case#: Case 1, Boy, Death at 6-7 months old, Hispanic

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002240, HP:0001640, 0000961, HP:0002090, HP:0001270, HP:0031664, HP:0200128, HP:0001252

      (Hepatomegaly, Cardiomegaly, Cyanosis, Pneumonia, Motor delay, Systolic heart murmur, Biventricular hypertrophy, Muscular Hypotonia)

      CaseHPOFreeText: Heart failure, Systolic murmur grade II-III, Enlarged, EKG showed an inverted T wave from V4-V6 as well as AVF, suggesting left systolic overload.

      CaseNotHPOs:

      CaseNotHPOFreeText:

      CasePreviousTesting: Ejection fraction of 52%

      Serum creatine kinase was 386 IU/L (mildly elevated)

      GAA activity on dried blood spot was decreased (1.08 nmol/L; normal range: 1.5-10 nmol/L)

      Whole exon and exon-intron boundaries direct sequencing revealed a homozygous single base deletion c.1987delC

      Variant: c.1987delC

      ClinVar: N/A

      CAID: N/A

      gnomAD: N/A

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    1. A male child, diagnosed with IOPD at the age of 3 months

      Case#: case 1, male, 3 months old at diagnosis, ethnicity unknown

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001638, HP:0001252 (cardiomyopathy, muscular hypotonia)

      CaseHPOFreeText: (Associated with Pompe Disease): Interventricular septum hypertrophy, increased serum CK, increased serum tryptase

      CaseHPOFreeText: (Infussion associated reactions) Urticarial rash, unresponsive to antihistamines and corticosteroids

      CaseNotHPOs:

      CaseNotHPOFreeText: Infusion associated reactions are not associated with an IgE mediated mechanism.

      CasePreviousTesting:

      GAA activity on fibroblast is 0.8 nmol/mg prot/h with a reference range of 64.4 ± 22.9 nmol/mg prot/h

      GAA activity on lymphocytes is 2.2 nmol 4 Mu/mg prot/h with a reference range of 21.4 ± 6.2 nmol 4 Mu/mg prot/h

      Variants:<br /> Variant 1: NM_000152.5(GAA):c.236_246del (p.Pro79fs)

      ClinVar: 371302

      CAID: 16041880

      Variant 2: NM_000152.5(GAA):c.1655T>C (p.Leu552Pro)

      ClinVar:279811

      CAID: 8815429

      gnomAD: N/A

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    2. Case 2A 50-day-old male infant was diagnosed with IOPD (Table 1)

      Case#: Case 2, male, 50 days old when diagnosed, ethnicity unknown

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001638, HP:0001252, HP:0000282 (cardiomyopathy, muscular hypotonia, facial edema)

      CaseHPOFreeText:(Associated to Pompe disease) increased serum CK.

      CaseHPOFreeText: (Infussion associated reactions) Generalized rash, cough and bronchospasm

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: Infusion associated reactions are not associated with an IgE mediated mechanism.

      CasePreviousTesting: See Table 1 for reports on GAA metabolic activity.

      GAA activity in dried blood spots is 0 μmol/l/h with a reference range of 1.86–21.9 μmol/l/h

      GAA activity on lymphocytes is 0.5 nmol 4 Mu/mg prot/h with a reference range of 21.4 ± 6.2 nmol 4 Mu/mg prot/h

      Variant: c1124G>T (p.R375L)

      ClinVar: N/A

      CAID: N/A

      gnomAD: N/A

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    1. PATIENT 3

      Case#: Patient 3, male, 21 year old, ethnicity unknown

      DiseaseAssertion: Pompe disease

      FamilyInfo: No family history of muscle disease

      CasePresentingHPOs: HP:0003236, HP:0100284

      (Elevated serum creatine kinase, EMG: myotonic discharges

      CaseHPOFreeText: Mild weakness (4/5) of iliopsoas muscles

      Myotonic discharges in the lumbar paraspinal muscles

      Elevated aspartate aminotransferase of 172 I/U ( Normal range 19–55 I/U)

      Elevated alanine aminotransferase of 203 I/U (Normal range 19–72 I/U)

      Serum CK was elevated at 1,373 U/L (normal range 70–185 U/L)

      CaseNotHPOs:

      CaseNotHPOFreeText: Normal alkaline phosphatase and γ-glutamyl transpeptidase levels.

      Liver ultrasound and biopsy at an outside facility were normal

      CasePreviousTesting: GAA level was 1.4 pmol/punch/h (normal range 10–49 pmol/punch/h)

      Variant 1: NM_000152.5(GAA):c.-32-13T>G

      ClinVar: 4027

      CAID: CA116606

      gnomAD: Hughest population MAF= 0.005541 (Ashkenazi Jewish)

      Variant 2: NM_000152.5(GAA):c.877G>A (p.Gly293Arg)

      ClinVar: 4036

      CAID: CA116622

      gnomAD: Highest population MAF= 0.00005704 (Latinos)

      ParentalGenotype:N/A

      PreviouslyPublished:N/A

    2. PATIENT 2

      Case#: Patient 2, Male, 71 year old, ethnicity unknown

      DiseaseAssertion: Pompe disease

      diagnosed at age 52 with SMA type III following an EMG reporting neurogenic changes and a muscle biopsy from a hamstring muscle that demonstrated denervation atrophy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0003701, HP:0003445

      (Proximal muscle weakness, EMG:neuropathic changes

      CaseHPOFreeText: Normal strength in the upper extremities with moderate weakness of hip flexion at 3/5, hip abduction 3–4/5, hip adduction 3–4/5, and hamstrings 4/5.

      EMG showed myotonic discharges in the anterior tibialis, medial gastrocnemius, iliopsoas, tensor fasciae latae, and biceps brachii muscles.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      Staining for PAS and acid phosphatase was normal.

      Serum CK was 208 U/L (normal range 70–185)

      CasePreviousTesting: GAA activity was 1.3pmol/punch/h (normal 10–49 pmol/punch/h) and he was found to have 2 heterozygous mutations

      Variant 1: NM_000152.5(GAA):c.-32-13T>G

      ClinVar: 4027

      CAID: CA116606

      gnomAD: Highest population MAF= 0.005541 (Ashkenazi Jewish)

      Variant 2: NM_000152.5(GAA):c.1841C>A (p.Thr614Lys)

      ClinVar: 167113

      CAID: CA234050

      gnomAD: Highest population MAF= 0.00004784 (European nin-Finnish)

      ParentalGenotype:N/A

      PreviouslyPublished:N/A

    3. PATIENT 1

      Case#: Patient 1, woman, 58 years old, ethnicity unknown

      DiseaseAssertion:Pompe disease

      Was also misdiagnosed with adult-onset spinal muscular atrophy (SMA)

      FamilyInfo: No family history of muscle disease

      CasePresentingHPOs: HP:0003701, HP:0100284

      (Proximal muscle weakness, EMG myotonic discharges)

      CaseHPOFreeText: Denervation atrophy from a muscle biopsy

      Weakness of hip flexion 2–3/5, hip abduction 2/5, and hip adduction 2/5

      Myotonic discharges were in the lumbar paraspinals, vastus medialis, and tensor fasciae latae muscles.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: GAA enzyme activity assay was 1 pmol/punch/h (normal range 10–49 pmol/punch/h)

      Her creatine kinase (CK) level at presentation had been elevated as high as 429 U/L (normal range 45–145)

      Found with two mutations in the GAA gene

      Variant: NM_000152.5(GAA):c.-32-13T>G

      ClinVar: 4027

      CAID: CA116606

      gnomAD: Highest population MAF= 0.005541 (Ashkenazi Jewish)

      Variant: NM_000152.5(GAA):c.525del (p.Glu176fs) Double check this variant

      ClinVar: 4033

      CAID: CA220406

      gnomAD: N/A

      ParentalGenotype:N/A

      Previously Published: N/A

    1. 87

      Case#: 87, Gender N/A, 6 months old when diagnosed, Asian

      DiseaseAssertion:Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: N/A

      CaseHPOFreeText:N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: The patient did not present any symptoms, diagnosed was made based on the predicted impact of the variant by PolyPhen-2

      CasePreviousTesting: The GAA gene was sequenced using NGS and resequenced for confirmation using Sanger.

      Dried Blood spot test found an GAA activity of 4.6 pmol/h/disk with a reference value of 6.5 pmol/h/disk

      enzyme activity in fibroblast was recorded to be 5.4 nmol/h/mg protein.

      Variants: Variant1: (Two mutated alleles with heterozygous mutations)

      Variant1.1: NM_000152.5(GAA):c.752C>T (p.Ser251Leu)

      ClinVar: 346310

      CAID: CA8815007

      gnomAD: Highest population MAF = 0.002234 (East Asian)

      Variant1.2: NM_000152.5(GAA):c.761C>T (p.Ser254Leu)

      ClinVar: 330447

      CAID: CA8815009

      gnomAD: Highest popu;ation MAF= 0.002235 (East Asians)

      Variant2: NM_000152.5(GAA):c.2003A>G (p.Tyr668Cys)

      ClinVar: 546808

      CAID: N/A

      gnomAD: N/A

      ParentalGenotype:N/A

      PreviouslyPublished:N/A

    2. 84

      Case#: 84, Gender N/A, 6 months old when diagnosed, Asian

      DiseaseAssertion: Pompe disease

      FamilyInfo: Both parents were tested for variants in GAA

      CasePresentingHPOs: N/A

      CaseHPOFreeText:N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: The patient did not present any symptoms, diagnosed was made based on the predicted impact of the variant by PolyPhen-2

      CasePreviousTesting: The GAA gene was sequenced using NGS and resequenced for confirmation using Sanger.

      Dried Blood spot test found an GAA activity of 3.8 pmol/h/disk with a reference value of 6.5 pmol/h/disk

      enzyme activity in fibroblast was recorded to be 3.0 nmol/h/mg protein.

      Variants: Variant1: (Two mutated alleles with heterozygous mutations)

      Variant1.1: NM_000152.5(GAA):c.752C>T (p.Ser251Leu)

      ClinVar: 346310

      CAID: CA8815007

      gnomAD: Highest population MAF = 0.002234 (East Asian)

      Variant1.2: NM_000152.5(GAA):c.761C>T (p.Ser254Leu)

      ClinVar: 330447

      CAID: CA8815009

      gnomAD: Highest popu;ation MAF= 0.002235 (East Asians)

      Variant2: C.1244C>T

      ClinVar: N/A

      CAID: N/A

      gnomAD: N/A

      ParentalGenotype: The c.752C>T+c.761C>T and c.1244C>T of subject ID 84 were derived from mother and father, respectively

      PreviouslyPublished:N/A

    3. 93

      Case#: 93, gender N/A, 6months old when diagnosed, Asian

      DiseaseAssertion: Pompe disease

      FamilyInfo: Both parents were carriers of mutations in the GAA gene. The patient inherited the mutations.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: Symptoms were noted at the age of 2.7 months old

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: The patient showed no symptoms but LOPD was diagnosed based on the predicted impact of the variants by PolyPhen-2

      CasePreviousTesting: The GAA gene was sequenced using NGS and resequenced for confirmation using Sanger.

      Dried Blood spot test found an GAA activity of 0.25 pmol/h/disk with a reference value of 6.5 pmol/h/disk

      Variant1: NM_000152.5(GAA):c.317G>A (p.Arg106His)

      ClinVar: 286481

      CAID: CA8814849

      gnomAD: MAF=0.0001094 in East Asian

      Variant2: (COMBINATION OF MUTATIONS IN THIS ALLELE, DOUBT HERE)

      Variant2.1: NM_000152.5(GAA):c.752C>T (p.Ser251Leu)

      ClinVar: 346310

      CAID: CA8815007

      gnomAD: Highest population MAF = 0.002234 (East Asian)

      Variant2.2: NM_000152.5(GAA):c.761C>T (p.Ser254Leu)

      ClinVar: 330447

      CAID: CA8815009

      gnomAD: Highest population MAF= 0.002235 (East Asians)

      ParentalGenotype: Father is heterozygous for c.317G>A (p.Arg106His).

      Mother carries both mutations of c.[752C>T,761C>T].

      PreviouslyPublished:N/A

    1. The patient, a 61‐year-old woman,

      Case#: Patient, female, 61 years old, ethnicity unknown

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0040213, HP:0010535, HP:0003326, HP:0002273, HP:0002877 (Hypopnea, Sleep Apnea, Myalgia, Tetraparesis, Nocturnal hypoventilation)

      CaseHPOFreeText: Sleep Apnea-Hypopnea Syndrome (SAHS), predominantly proximal tetraparesis

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: Serum measurements were normal, includind Creatine Phosphokinase levels (CPK)

      CasePreviousTesting: GAA enzyme level 0.72 µkat/kg was significantly reduced in lymphocytes with a reference range of 4.8–13.3 µkat/kg protein. This test was done with maltase-glucoamylase inhibitor acarbose

      All exons and flanking introns were bidirectionally sequenced after PCR amplification. "sequence-analysis of GAA transcripts"

      Variant: c.1194+5G>A

      ClinVar:

      CAID:CA658795243

      gnomAD:

      ParentalGenotype:

      PreviouslyPublished: N/A